Clinical Study

Gemcitabine/Abraxane Chemotherapy And Dose Escalated Radiotherapy For Locally Advanced, Unresectable Pancreatic Cancer

Posted Date: May 15, 2019

  • Investigator: Olugbenga Olowokure
  • Specialties:
  • Type of Study: Drug

Patients will get gemcitabine combined with Abraxane, then gemcitabine in combination with radiation therapy. Abraxane is a chemotherapy drug that may help treat pancreatic cancer by allowing gemcitabine to further penetrate the tumor in the pancreas. This study will analyze the good and bad effects

Criteria:

Eligible Patients Must Have A Confirmed Diagnosis Of Adenocarcinoma Of The Pancreas, Locally Advance

Keywords:

Gastrointestinal Can, Gi Cancer, Pancreatic Cancer, Ucci-Gi-01, Unresectable

For More Information:

Uc Cancer Institute
513-584-7698
kastla@ucmail.uc.edu


  • This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
    For questions regarding clinical studies at UC Health, contact us at ResearchStudies@UCHealth.com or (513) 245-3417.